Omega Therapeutics Announces $40 Million Registered Direct Offering of Common Stock
Omega Therapeutics CAMBRIDGE, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) — Omega Therapeutics, Inc. (Nasdaq: OMGA)
Omega Therapeutics CAMBRIDGE, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) — Omega Therapeutics, Inc. (Nasdaq: OMGA)
Omega Therapeutics CAMBRIDGE, Mass., Jan. 17, 2023 (GLOBE NEWSWIRE) — Omega Therapeutics, Inc. (Nasdaq: OMGA)